Calamos Wealth Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $56k 55k 1.01
2023-09-30 $88k 78k 1.12

More positions owned by Calamos Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 3000 Etf (IWV)
Amazon (AMZN)
Ishares Tr Core S&p Scp Etf (IJR)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Acwi Ex Us (ACWX)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
UnitedHealth (UNH)
Visa Com Cl A (V)

View all positions for Calamos Wealth Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
New York State Common Retirement Fund
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1